Clinical Trials Directory

Trials / Completed

CompletedNCT04909177

oVRcome Self-guided Virtual Reality for Specific Phobias

oVRcome Self-guided Virtual Reality for Specific Phobias: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
126 (actual)
Sponsor
University of Otago · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Specific phobias: fear of flying, heights, spiders, dogs and needles are the extremely common and exposure therapy (ET) is the first line of treatment. Using Virtual Reality (VR), participants will have control in gradual exposure to their fears. oVRcome (https://www.ovrcome.io/ Virtual reality app), is a self-help VRET for specific phobias, that is delivered through a smartphone application (app) in combination with a low cost headset that holds the smartphone and uses 360º video. The investigators hypothesize that oVRcome is effective in reducing specific phobia symptoms.

Conditions

Interventions

TypeNameDescription
OTHERSmartphone application (app) in combination with headsetThe intervention oVRcome is self-help VRET for specific phobia, that is delivered through a smartphone application (app) in combination with headset that holds the smartphone and uses 360º video. oVRcome includes 6 modules of psychoeducation, relaxation, mindfulness, cognitive techniques, exposure through VR, and a relapse prevention module which are aimed to be completed weekly.

Timeline

Start date
2021-06-02
Primary completion
2021-09-07
Completion
2022-03-07
First posted
2021-06-01
Last updated
2024-08-22

Locations

1 site across 1 country: New Zealand

Source: ClinicalTrials.gov record NCT04909177. Inclusion in this directory is not an endorsement.